FIX-SDM Program for Lung Cancer Screening

(FIX-SDM LCS Trial)

This trial tests a new support program called FIX-SDM, designed to help patients and healthcare providers make better decisions together about lung cancer screening. The trial aims to determine if this program increases the number of people completing their lung cancer screenings. It will compare this approach to regular care to assess improvements in decision-making and screening rates. Individuals who currently smoke or quit smoking within the last 15 years, have a history of smoking at least 20 pack-years, and have an upcoming doctor's visit might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative approaches in healthcare decision-making.

The trial information does not specify whether you need to stop taking your current medications. It seems focused on lung cancer screening and decision-making support, so it's unlikely that your current medications would be affected.

In a previous study, participants who engaged in shared decision-making for lung cancer screening felt more comfortable discussing their screening results with their doctors. This finding indicates that the FIX-SDM program, which includes educational materials and support sessions, is generally well-received by both patients and healthcare providers. No reports of negative effects linked to the support program itself emerged. By focusing on communication and decision-making, this type of program carries minimal risk to participants. Overall, available research suggests that the FIX-SDM program is safe for participants.¹²³⁴⁵

Researchers are excited about the FIX-SDM program because it aims to improve lung cancer screening by enhancing the decision-making process for both patients and primary care providers. Unlike the usual care, which primarily relies on standard e-alert notifications, FIX-SDM provides additional educational support, a smoking history survey, and text message reminders to better prepare patients for their primary care visits. This proactive approach is designed to engage patients more effectively and facilitate shared decision-making, potentially leading to earlier detection and improved outcomes in lung cancer screening.

Studies have shown that shared decision-making (SDM) can significantly improve outcomes in lung cancer screening. Research indicates that an enhanced SDM process helps patients better understand screening, reduces decision-making stress, and increases their willingness to undergo screenings. Specifically, programs incorporating SDM have demonstrated a small but clear increase in the number of individuals screened for lung cancer. For instance, programs involving both patients and doctors can double the likelihood of patients completing lung cancer screenings. This trial will test the FIX-SDM program, where primary care providers receive additional support and educational materials to enhance SDM. Overall, SDM tools assist patients by making the screening process easier to understand and more acceptable.²⁴⁵⁶⁷